Purchase Order 75N95021P00502

Award Date 8/31/21
Potential Completion Date 9/30/22
Potential Value $3.9M
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Danaher Corporation
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $168,841.20 firm-fixed-price purchase order to Molecular Devices LLC, a subsidiary of Danaher Corporation, to provide an upgrade to the FLIPR Tetra high-throughput cellular screening system. This includes the installation of a high-speed electron multiplying charge-coupled device (HS-EMCCD) camera and associated Peak Pro 2 software. The upgrade will...
This purchase order awards Molecular Devices LLC $293,764 to upgrade a Molecular Devices ImageXpress System for the National Center for Advancing Translational Sciences at the National Institutes of Health. The solicitation sought proposals for a high-performance 7 line laser light source, asynchronous dispense software, installation, and operational training to support the system. As the sole anticipated awardee and brand name equipment provider, Molecular Devices will deliver the requested...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $208,187.00 contract provides an annual service agreement for Molecular Devices' FLIPR Tetra high-throughput cellular screening systems, which are used in NCATS' research on GPCR, ion channel, and stem cell projects with implications for pain and opioid...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Molecular Devices LLC for a FLIPR PENTA/TETRA PIPETTOR HEAD KIT, 384-WELL WITH TETRA PIPET TIPS. The $96,747.00 contract supports the Antiviral Program for Pandemics Project within NCATS' Division of Preclinical Innovation and does not have a set-aside designation. Molecular Devices LLC, a subsidiary of Danaher Corporation,...
Molecular Devices LLC was awarded a definitive contract valued at $658,099 by the National Institutes of Health National Institute on Drug Abuse to deliver one Molecular Devices FLIPR Penta high-throughput cellular screening system. The firm fixed price contract runs from September 24, 2020 through March 24, 2021. The prime contractor, Molecular Devices LLC, a division of Danaher Corporation, will provide the requested products and services to the NIH campus in Rockville, Maryland. The...
This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Molecular Devices LLC for the provision of an ImageXpress Micro Confocal High Content Screening System. The $586,048.77 contract, which does not have a set-aside designation, has an ultimate completion date of May 15, 2017. Molecular Devices LLC, a division of Danaher Corporation, is a leading provider of bioanalytical measurement...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $32,986.00 firm fixed price purchase order to Life Technologies Corporation, a for-profit manufacturer, for an iBright FL 1500 Imaging System. This non-competitive award was issued under simplified acquisition procedures without a set-aside designation. The solicitation was posted on March 30, 2020 and the award was made on April 8, 2020 for delivery within 6...
This is a $249,827.18 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the supply of a QPIX Microbial Colony Picker, a specialized laboratory instrument used in life sciences research and drug discovery. Molecular Devices LLC, the prime contractor, is a leading provider of...
The Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $205,543 firm fixed price purchase order to Molecular Devices LLC for a maintenance and service agreement for an ImageXpress Micro confocal high-content imaging system. The place of performance will be Molecular Devices LLC's San Jose, California facility. The agreement runs from November 2020 through November 2024 to provide support for the imaging...
Molecular Devices LLC was awarded a $38,056 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The award is to provide a GXP software bundle package, additional user licenses, annual maintenance and technical support, and installation services to upgrade three Molecular Devices readers currently used by the Vaccine Immunology Program at the Vaccine Research Center facility in...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $3.86 million firm fixed price purchase order to Molecular Devices LLC for the acquisition of five Molecular Devices ImageXpress Confocal High-Content Imaging Systems, one FLIPR Penta high-throughput cellular screening system, along with associated software, services, consumables, installation, training, customization, maintenance, and technical support. The products and services are to support the agency's coronavirus COVID-19 antiviral initiative. Funding is provided by the Department of Health and Human Services. Performance will take place at Molecular Devices' facilities in San Jose, California through September 2022. The award was made non-competitively from solicitation number 75N95021Q00379 to acquire the specified Molecular Devices and FLIPR Penta systems in direct support of NCATS' research efforts.

Generated 12/29/23, 2:35 PM